Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

Ann Oncol. 2024;35(3):248-266.
J. Ledermann, X. Matias-Guiu, F. Amant, et al.

  • 46 participants from 15 countries across Europe, Asia and the USA contributed to the ESGO–ESMO–ESP consensus conference.
  • Recommendations cover diagnosis and management of early, advanced and recurrent ovarian cancers.
  • Recommendations are based on available data and/or the experts’ collective, multidisciplinary opinions and experience.
  • The results, including questions, recommendations and supporting evidence for each recommendation, are detailed here.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.